CA1026673A - Composes pharmaceutiques - Google Patents

Composes pharmaceutiques

Info

Publication number
CA1026673A
CA1026673A CA194,258A CA194258A CA1026673A CA 1026673 A CA1026673 A CA 1026673A CA 194258 A CA194258 A CA 194258A CA 1026673 A CA1026673 A CA 1026673A
Authority
CA
Canada
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA194,258A
Other languages
English (en)
Inventor
Roger Camble
Harold Gregory
Ernest E.L. Gerring
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB1485073A external-priority patent/GB1417776A/en
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Application granted granted Critical
Publication of CA1026673A publication Critical patent/CA1026673A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA194,258A 1973-03-28 1974-03-06 Composes pharmaceutiques Expired CA1026673A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1485073A GB1417776A (en) 1973-03-28 1973-03-28 Pharmaceutical compositions
GB1570673 1973-04-02

Publications (1)

Publication Number Publication Date
CA1026673A true CA1026673A (fr) 1978-02-21

Family

ID=26250838

Family Applications (1)

Application Number Title Priority Date Filing Date
CA194,258A Expired CA1026673A (fr) 1973-03-28 1974-03-06 Composes pharmaceutiques

Country Status (7)

Country Link
US (1) US3917824A (fr)
CA (1) CA1026673A (fr)
DE (1) DE2415101C2 (fr)
FR (1) FR2223033B1 (fr)
IE (1) IE38892B1 (fr)
IL (1) IL44288A (fr)
NL (1) NL7403810A (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4070451A (en) * 1976-11-02 1978-01-24 Howard Price Hoof care emulsion or cream
JPS609795B2 (ja) * 1980-12-11 1985-03-13 株式会社林原生物化学研究所 ヒト上皮細胞成長因子の製造方法
US5240912A (en) * 1983-05-09 1993-08-31 Todaro George J Transforming growth factor (TGF) peptides
IL69719A0 (en) * 1983-09-14 1983-12-30 Yeda Res & Dev Synthetic peptides with egf like activity
JPS62501071A (ja) * 1984-10-30 1987-04-30 オンコゲン 成長因子活性を有する新規なポリペプチド及び該ポリペプチドをコ−ドする核酸配列
US4743679A (en) * 1986-02-24 1988-05-10 Creative Biomolecules, Inc. Process for producing human epidermal growth factor and analogs thereof
IN165717B (fr) * 1986-08-07 1989-12-23 Battelle Memorial Institute
US4929442A (en) * 1986-09-26 1990-05-29 Exovir, Inc. Compositions suitable for human topical application including a growth factor and/or related materials
WO1989001489A1 (fr) * 1987-08-10 1989-02-23 Commonwealth Scientific And Industrial Research Or Regulation de l'angiogenese et compositions et procedes prevus a cet effet
US5222978A (en) * 1987-08-26 1993-06-29 United States Surgical Corporation Packaged synthetic absorbable surgical elements
US5226912A (en) * 1987-08-26 1993-07-13 United States Surgical Corporation Combined surgical needle-braided suture device
US5472702A (en) * 1987-08-26 1995-12-05 United States Surgical Corporation Sterilization of growth factors
US5306289A (en) * 1987-08-26 1994-04-26 United States Surgical Corporation Braided suture of improved characteristics
US5366081A (en) * 1987-08-26 1994-11-22 United States Surgical Corporation Packaged synthetic absorbable surgical elements
US5218093A (en) * 1989-03-01 1993-06-08 Allelix Biopharmaceuticals, Inc. EGF variants and pharmaceutical use thereof
US5359831A (en) * 1989-08-01 1994-11-01 United States Surgical Corporation Molded suture retainer
IT1240683B (it) * 1990-04-26 1993-12-17 Zambon Spa Composizione farmaceutica contenente egf
DK0541726T3 (da) * 1990-08-02 2000-08-21 Indu Parikh Vækstfaktorsammensætninger, fremstilling og anvendelse
US5434135A (en) * 1990-08-02 1995-07-18 Indu Parikh Growth factor compositions, preparation and use
US5360790A (en) * 1990-12-11 1994-11-01 The Regents Of The University Of Michigan Method and formulations for the therapy of acute renal failure
CA2059245C (fr) * 1991-02-08 2004-07-06 Michael P. Chesterfield Methode et appareil permettant de laminer et d'enrober ou de remplir des jonctions
AU2489992A (en) * 1991-08-16 1993-03-16 Chiron Corporation Muteins of epidermal growth factor exhibiting enhanced binding at low ph
US6558952B1 (en) * 1992-12-14 2003-05-06 Waratah Pharmaceuticals, Inc. Treatment for diabetes
US5965530A (en) * 1993-03-26 1999-10-12 Amgen Inc. Therapeutic uses of keratinocyte growth factor
US6743422B1 (en) 1996-10-15 2004-06-01 Amgen, Inc. Keratinocyte growth factor-2 products
US20030144202A1 (en) * 1996-10-15 2003-07-31 Amgen Inc. Uses of keratinocyte growth factor-2
US20040037818A1 (en) * 1998-07-30 2004-02-26 Brand Stephen J. Treatment for diabetes
US20060014684A1 (en) * 2000-03-03 2006-01-19 University Technologies International Inc. Novel uses of EGF
RU2234216C2 (ru) * 2000-10-10 2004-08-20 Джапэн Эз Репрезентед Бай Президент Оф Ниигата Юниверсити Способ получения животного со стойкими сенсомоторными и поведенческими нарушениями (варианты) и применение трансгенного по эпидермальному фактору роста животного в качестве модели животного со стойкими сенсомоторными и поведенческими нарушениями (варианты)
JP2004520345A (ja) * 2001-01-12 2004-07-08 ワラター・ファーマシューティカルズ・インク 糖尿病を有する被験者にガストリン／ｃｃｋ受容体リガンド及びｅｇｆ受容体リガンド組成物を用いた島細胞新生治療方法の効果持続
US7037504B2 (en) * 2001-10-23 2006-05-02 Waratah Pharmaceuticals, Inc. Epidermal growth factor protein and gene, and methods of use therefor
WO2003035102A1 (fr) * 2001-10-26 2003-05-01 University Technologies International, Inc. Utilisation de l'egf pour inhiber les infections pathogenes du tractus urogenital
US20060234373A1 (en) * 2002-05-24 2006-10-19 Alex Rabinovitch Treatment for diabetes
KR100711145B1 (ko) * 2002-07-03 2007-04-24 (주)넥스젠 상피세포재생인자 및 인간 혈청 알부민을 포함하는 융합폴리펩타이드
US20090192554A1 (en) 2008-01-29 2009-07-30 Confluent Surgical, Inc. Bioabsorbable block copolymer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE362789B (fr) * 1965-03-03 1973-12-27 Teikoku Hormone Mfg Co Ltd

Also Published As

Publication number Publication date
IE38892B1 (en) 1978-06-21
IL44288A (en) 1977-02-28
US3917824A (en) 1975-11-04
AU6594974A (en) 1975-08-28
IL44288A0 (en) 1974-05-16
FR2223033A1 (fr) 1974-10-25
DE2415101C2 (de) 1984-08-30
DE2415101A1 (de) 1974-10-10
NL7403810A (fr) 1974-10-01
FR2223033B1 (fr) 1978-07-28
IE38892L (en) 1974-09-28

Similar Documents

Publication Publication Date Title
CA1030871A (fr) Compose pharmaceutique
CA1026673A (fr) Composes pharmaceutiques
CA1030859A (fr) Melanges de polyolefines et d'elastomeres
AU472941B2 (en) Pharmaceutical compositions
AU498989B2 (en) Pharmaceutical compositions
ZA744373B (en) Pharmaceutical compositions
AU7201374A (en) Pharmaceutical compositions
ZA744488B (en) Pharmaceutical compositions
ZA745756B (en) Pharmaceutical compositions
CA1024892A (fr) Preparation pharmaceutiques renfermant des derives de triazolo-isoquinoleine
CA1032873A (fr) Shampooings
ZA742064B (en) Pharmaceutical compositions
ZA747276B (en) Pharmaceutical compositions
ZA746271B (en) Pharmaceutical compositions
CA1011252A (en) Dihydrocanadensolide compositions
AU499890B2 (en) Oral compositions
ZA741050B (en) Pharmaceutical compositions
AU471794B2 (en) Iodophor-steroid pharmaceutical compositions
AU492729B2 (en) Pharmaceutical compositions
AU494300B2 (en) Pharmaceutical compositions
AU485568B2 (en) Pharmaceutical compositions
AU493221B2 (en) Pharmaceutical compositions
AU478769B2 (en) Pharmaceutical compositions
AU480639B2 (en) Pharmaceutical compositions containing triazolo-isoquinoline derivatives
AU486937B2 (en) Shampoo compositions